Home › Grants › United States

Funding programs in United States

Hand-checked programs plus official open data. Each links to its official page. Loans and private funders are labelled.

United States grant list United States funders United States student funding guide

Open-data catalog: Nonprofits and charities

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 15 June 2027
BRAIN Initiative: Brain-Behavior Quantification and Synchronization - Transformative Research on Behavior at the Organismal Level · National Institutes of Health · United States (federal) · Forecast
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System · National Institutes of Health · United States (federal) · Forecast
BRAIN Initiative: Data Archives for the BRAIN Initiative · National Institutes of Health · United States (federal) · Forecast
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research · National Institutes of Health · United States (federal) · Forecast
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 February 2027
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 11 February 2027
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 23 June 2028
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 28 January 2027
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 15 June 2027
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 February 2029
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 6 October 2028
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 8 November 2027
Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (Assistance Listing 93.BZ1) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Bridge2AI Network for AI Health Science · National Institutes of Health · United States (federal) · Forecast
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 25 January 2027
Cancer Biology Research (Assistance Listing 93.396) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Cancer Cause and Prevention Research (Assistance Listing 93.393) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 25 September 2028
Cancer Centers Support Grants (Assistance Listing 93.397) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Cancer Detection and Diagnosis Research (Assistance Listing 93.394) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 7 January 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Closes 25 October 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) · National Institutes of Health · United States (federal) · Closes 25 October 2027
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cancer Research Manpower (Assistance Listing 93.398) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cancer Treatment Research (Assistance Listing 93.395) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect · National Institutes of Health · United States (federal) · Forecast
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 9 February 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 12 November 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 12 November 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 23 December 2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 23 December 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials · National Institutes of Health · United States (federal) · Closes 23 December 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allow · National Institutes of Health · United States (federal) · Closes 23 December 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 23 December 2027
Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 5 July 2029
CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 5 November 2028
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 23 November 2026
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) · National Institutes of Health · United States (federal) · Closes 23 November 2026
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 23 November 2026
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Forecast
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 25 May 2029
Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Centers for Genomics Research Capacity Building · National Institutes of Health · United States (federal) · Forecast
Centers for Research on Neglected Infectious Diseases · National Institutes of Health · United States (federal) · Forecast
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 28 May 2027
Centers of Excellence in Genomic Science (CEGS) · National Institutes of Health · United States (federal) · Forecast
Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD) · National Institutes of Health · United States (federal) · Forecast
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 12 July 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 18 November 2027
Child Health and Human Development Extramural Research (Assistance Listing 93.865) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Child Health and Human Development Extramural Research Projects (Assistance Listing 93.HDR) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Child Health and Human Development Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative (Assistance Listing 93.HDM) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Child Health and Human Development Other Research (Assistance Listing 93.HDT) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Child Health and Human Development Research Centers (Assistance Listing 93.HDC) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Child Health and Human Development Research Training - Individual Awards (Assistance Listing 93.HDD) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Child Health and Human Development Research Training - Institutional Awards (Assistance Listing 93.HDN) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Childhood Asthma in Urban Settings Clinical Research Network · National Institutes of Health · United States (federal) · Forecast
Claude D. Pepper Older Americans Independence Centers · National Institutes of Health · United States (federal) · Forecast
Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Clinical and Translational Science Award · National Institutes of Health · United States (federal) · Forecast
Clinical and Translational Science Award (UM1 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 28 September 2027
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 January 2028
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 2 November 2028
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Clinical Data Ecosystem for Genomics (CDEG) · National Institutes of Health · United States (federal) · Forecast
Clinical Data, Safety and Statistical Centers (CDSSC) · National Institutes of Health · United States (federal) · Forecast
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 2 November 2026
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) · National Institutes of Health · United States (federal) · Closes 10 November 2026
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Closes 20 July 2028
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required) · National Institutes of Health · United States (federal) · Forecast
Clinical Trials in Organ Transplantation in Children and Adults · National Institutes of Health · United States (federal) · Forecast
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Co-infection and Cancer (R21 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Forecast
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 26 September 2029
Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Common Fund (Assistance Listing 93.1CF) · Health And Human Services, Department Of / National Institutes Of Health · United States (federal) · Dates vary
Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional) · National Institutes of Health · United States (federal) · Recurring, next intake TBA
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 16 November 2028
Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional) · National Institutes of Health · United States (federal) · Closes 7 May 2028

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.